| Liver Transplantation, Molecular Motors Receive Lasker Awards | | The newest advertising blitz of caffeinated-drug company Starbucks comes in the form of encouraging readers to share their favorite fall moments, with the Pumpkin Spice Latte featuring prominently, in tweets that include the hashtag #itsfallwhen. Well, in biomedical science, it's fall when the Lasker Awards are announced. Find out the details. |  |
| Health Care & Policy |  |  | | - FDA will consider expanded use of Shire's ADHD drug Vyvanse
The FDA accepted Shire's regulatory application for Vyvanse, or lisdexamfetamine dimesylate, as a maintenance drug for attention-deficit/hyperactivity disorder among 6- to 17-year-olds. The drug is approved to treat children, adolescents and adults with ADHD as part of an overall treatment plan and as maintenance therapy for adults with ADHD. The FDA is expected to conclude its review of the additional indication by April. Drug Store News (9/12)       - Sequencing of 1918 flu virus guides development of vaccines
Researchers who sequenced the genome of the 1918 pandemic flu virus have discovered that strains that caused pandemics in 1957, 1968 and 2009 were related to the 1918 virus. Experts said the discovery helps advance the understanding of flu biology and the development of "universal" vaccines, and may help make the response to potential pandemics more effective. InfectionControlToday.com (9/11) - Mutation identified as cause of hereditary xerocytosis
Canadian researchers reported the discovery of the genetic variation that causes hereditary xerocytosis, a disorder characterized by rapid destruction of red blood cells. The study involved the relatives of a woman from Manitoba, Canada. The discovery may offer clues about other inherited disorders involving red blood cells, a researcher said. The findings were published in the journal Blood. Winnipeg Free Press (Manitoba) (9/11)  | Fly a lot? Earn 3X rewards points on airline purchases with The Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, and shipping
• 1X points on everything else
• Limited Time Offer: 50K bonus points when you spend $5K in your first 3 months of Card membership†
LEARN MORE AND APPLY †Terms & Restrictions Apply. |
   | Two courses in four days at MIT Sloan Exec Ed
Learn from world-renowned faculty at MIT Executive Education and make the most of your visit with back-to-back two-day courses. Understand big data, revitalize your digital business model, solve complex business problems, drive strategic innovation. View 25+ short courses. |
 | Industry Deals | | | | - Summit licenses drug technology to Bristol
U.K. drug development company Summit granted Bristol-Myers Squibb the right to use its Seglin technology to identify and develop treatments for as many as 10 therapeutic targets. The licensing deal entitles Summit to $100,000 access payment and up to $30 million in research and development milestone fees for each product plus sales royalties. IFAMagazine.com (9/11), The Pharma Letter (U.K.) (subscription required) (9/12)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| Food & Agriculture | | | | | Industrial & Environmental | | | | | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the e-newsletter.
| SmartQuote | | | |  | Much may be done in those little shreds and patches of time which every day produces, and which many men throw away."
--Charles Caleb Colton,
British cleric and writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, September 12, 2012
- Tuesday, September 11, 2012
- Monday, September 10, 2012
- Friday, September 07, 2012
- Thursday, September 06, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment